6696.TWO
Price:
$412.5
Market Cap:
$34.12B
Lin BioScience, Inc., a drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases. Its product pipeline includes LBS-008, an oral therapy for dry age-related macular degeneration (Dry AMD)and stargardt diseases (STGD1), which is under Phase 3 clinical trial to evaluate safety and efficacy in adolescent STGD1 and under phase 2 or phase 3 clinical trial to evaluate safety and efficacy in Dry AMD; LBS-007, a natural non-ATP CDC7 inhibitor for the treatment of cancers; LBS-002, an anti-tubulin to treat primary and metastatic brain tumors; and LBS-009, an oral therapy for the treatment of non-alcoholic fatty liver disease and type 2 diabetes. The company is ...[Read more]
Industry
Biotechnology
IPO Date
2018-10-08
Stock Exchange
TWO
Ticker
6696.TWO
According to Lin BioScience, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 32.56B. This represents a change of 327.19% compared to the average of 7.62B of the last 4 quarters.
The mean historical Enterprise Value of Lin BioScience, Inc. over the last ten years is 7.39B. The current 32.56B Enterprise Value has changed 43.98% with respect to the historical average. Over the past ten years (40 quarters), 6696.TWO's Enterprise Value was at its highest in in the December 2022 quarter at 10.90B. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.
Average
7.39B
Median
7.37B
Minimum
1.73B
Maximum
11.92B
Discovering the peaks and valleys of Lin BioScience, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 202.74%
Maximum Annual Enterprise Value = 11.92B
Minimum Annual Increase = -49.53%
Minimum Annual Enterprise Value = 1.73B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 9.35B | 73.70% |
| 2023 | 5.38B | -49.53% |
| 2022 | 10.67B | -10.52% |
| 2021 | 11.92B | 127.11% |
| 2020 | 5.25B | 202.74% |
The current Enterprise Value of Lin BioScience, Inc. (6696.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.47B
5-year avg
8.52B
10-year avg
7.39B
Lin BioScience, Inc.’s Enterprise Value is greater than EirGenix Inc. (20.70B), greater than Polaris Group (24.32B), greater than Pell Bio-Med Technology Co., Ltd. (21.53B), greater than Caliway Biopharmaceuticals Co., Ltd. (18.05B), greater than Sunmax Biotechnology Co., Ltd. (20.32B), greater than Oneness Biotech Co., Ltd. (25.54B), greater than TaiMed Biologics Inc. (17.67B), greater than Center Laboratories, Inc. (32.33B), greater than Tanvex BioPharma, Inc. (16.48B), greater than AP Biosciences Inc (13.94B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 20.70B | $22.54B | |
| 24.32B | $22.34B | |
| 21.53B | $21.79B | |
| 18.05B | $25.62B | |
| 20.32B | $21.40B | |
| 25.54B | $27.99B | |
| 17.67B | $17.87B | |
| 32.33B | $27.05B | |
| 16.48B | $15.52B | |
| 13.94B | $15.24B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lin BioScience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lin BioScience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Lin BioScience, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Lin BioScience, Inc. (6696.TWO)?
What is the 3-year average Enterprise Value for Lin BioScience, Inc. (6696.TWO)?
What is the 5-year average Enterprise Value for Lin BioScience, Inc. (6696.TWO)?
How does the current Enterprise Value for Lin BioScience, Inc. (6696.TWO) compare to its historical average?